Chen S, Zhu H, Jounaidi Y
Signal Transduct Target Ther. 2024; 9(1):302.
PMID: 39511139
PMC: 11544004.
DOI: 10.1038/s41392-024-02005-w.
French A, Cron R, Cooper M
Adv Exp Med Biol. 2024; 1448:145-159.
PMID: 39117813
DOI: 10.1007/978-3-031-59815-9_11.
Aguilar O, Fong L, Lanier L
Immunol Rev. 2024; 323(1):40-53.
PMID: 38411263
PMC: 11102329.
DOI: 10.1111/imr.13313.
Di Vito C, Coianiz N, Calvi M, Terzoli S, Zaghi E, Puccio S
Front Immunol. 2024; 14:1266051.
PMID: 38268918
PMC: 10806243.
DOI: 10.3389/fimmu.2023.1266051.
Nabekura T, Deborah E, Tahara S, Arai Y, Love P, Kako K
Nat Commun. 2023; 14(1):7200.
PMID: 37938555
PMC: 10632368.
DOI: 10.1038/s41467-023-42578-8.
An inference model gives insights into innate immune adaptation and repertoire diversity.
Qin Y, Mace E, Barton J
Proc Natl Acad Sci U S A. 2023; 120(38):e2305859120.
PMID: 37695895
PMC: 10515141.
DOI: 10.1073/pnas.2305859120.
Natural killer cells in COVID-19: from infection, to vaccination and therapy.
Zafarani A, Razizadeh M, Pashangzadeh S, Amirzargar M, Taghavi-Farahabadi M, Mahmoudi M
Future Virol. 2023; .
PMID: 36936055
PMC: 10013930.
DOI: 10.2217/fvl-2022-0040.
Human natural killer cells: Form, function, and development.
Mace E
J Allergy Clin Immunol. 2022; 151(2):371-385.
PMID: 36195172
PMC: 9905317.
DOI: 10.1016/j.jaci.2022.09.022.
Uterine NK Cells Ace an "A" in Education: NKG2A Sets Up Crucial Functions at the Maternal-Fetal Interface.
Colucci F
J Immunol. 2022; 209(8):1421-1425.
PMID: 36192118
PMC: 7613701.
DOI: 10.4049/jimmunol.2200384.
Beyond Maternal Tolerance: Education of Uterine Natural Killer Cells by Maternal MHC Drives Fetal Growth.
Depierreux D, Kieckbusch J, Shreeve N, Hawkes D, Marsh B, Blelloch R
Front Immunol. 2022; 13:808227.
PMID: 35619712
PMC: 9127083.
DOI: 10.3389/fimmu.2022.808227.
Influence of Self-MHC Class I Recognition on the Dynamics of NK Cell Responses to Cytomegalovirus Infection.
Potempa M, Aguilar O, Gonzalez-Hinojosa M, Tenvooren I, Marquez D, Spitzer M
J Immunol. 2022; 208(7):1742-1754.
PMID: 35321880
PMC: 8976824.
DOI: 10.4049/jimmunol.2100768.
Making a Killer: Selecting the Optimal Natural Killer Cells for Improved Immunotherapies.
Barnes S, Trew I, de Jong E, Foley B
Front Immunol. 2021; 12:765705.
PMID: 34777383
PMC: 8578927.
DOI: 10.3389/fimmu.2021.765705.
Activation status dictates the function of unlicensed natural killer cells in mice and humans.
Aguilar E, Dunai C, Judge S, Zamora A, Khuat L, Vick L
Blood Adv. 2021; 5(20):4219-4232.
PMID: 34496010
PMC: 8945636.
DOI: 10.1182/bloodadvances.2021004589.
Licensing Natural Killers for Antiviral Immunity.
Cronk J, Fafoutis E, Brown M
Pathogens. 2021; 10(7).
PMID: 34358058
PMC: 8308748.
DOI: 10.3390/pathogens10070908.
The RNA m6A reader YTHDF2 controls NK cell antitumor and antiviral immunity.
Ma S, Yan J, Barr T, Zhang J, Chen Z, Wang L
J Exp Med. 2021; 218(8).
PMID: 34160549
PMC: 8225680.
DOI: 10.1084/jem.20210279.
Regulation of MHC I Molecules in Glioblastoma Cells and the Sensitizing of NK Cells.
Burster T, Gartner F, Bulach C, Zhanapiya A, Gihring A, Knippschild U
Pharmaceuticals (Basel). 2021; 14(3).
PMID: 33800301
PMC: 7998501.
DOI: 10.3390/ph14030236.
Transcriptional and epigenetic regulation of memory NK cell responses.
Beaulieu A
Immunol Rev. 2021; 300(1):125-133.
PMID: 33491231
PMC: 8726596.
DOI: 10.1111/imr.12947.
Soluble and Exosome-Bound α-Galactosylceramide Mediate Preferential Proliferation of Educated NK Cells with Increased Anti-Tumor Capacity.
Wagner A, Gehrmann U, Hiltbrunner S, Carannante V, Luu T, Naslund T
Cancers (Basel). 2021; 13(2).
PMID: 33467442
PMC: 7830699.
DOI: 10.3390/cancers13020298.
Airway Natural Killer Cells and Bacteria in Health and Disease.
Theresine M, Patil N, Zimmer J
Front Immunol. 2020; 11:585048.
PMID: 33101315
PMC: 7546320.
DOI: 10.3389/fimmu.2020.585048.
The Genetic Mechanisms Driving Diversification of the Gene Cluster in Primates.
Bruijnesteijn J, de Groot N, Bontrop R
Front Immunol. 2020; 11:582804.
PMID: 33013938
PMC: 7516082.
DOI: 10.3389/fimmu.2020.582804.